About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Anti-VEGF Market Size, Demand, Share, Report to 2030

Anti-VEGF Market

Anti-VEGF Market Size, Share & Trends Analysis Report By Product (Eylea, Lucentis, Beovu), By Disease (Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion, Age-Related Macular Degeneration), By Drug (Small Molecules, Biologics), By Type (VEGF-A Inhibitors, VEGF-B Inhibitors, VEGF-C Inhibitors, Placenta Growth Factor Inhibitors), By Distribution Channel (Hospitals, Specialty Clinics, Mail Order Pharmacies) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI1718DR
Study Period 2020-2032 CAGR 1.02%
Historical Period 2020-2022 Forecast Period 2024-2032
Base Year 2023 Base Year Market Size USD XX Billion
Forecast Year 2032 Forecast Year Market Size USD XX Billion
Largest Market North America Fastest Growing Market Europe
Show More
Buy Now
File Formats
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  1. Anti-VEGF Market, By Product (2022-2030)
    1. Eylea
    2. Lucentis
    3. Beovu
  2. Anti-VEGF Market, By Disease (2022-2030)
    1. Macular Edema
    2. Diabetic Retinopathy
    3. Retinal Vein Occlusion
    4. Age-Related Macular Degeneration
  3. Anti-VEGF Market, By Drug (2022-2030)
    1. Small Molecules
      1. Pazopanib
      2. Sunitinib
      3. Sorafenib
      4. Regorafenib
      5. Cabozantinib
      6. Lenvatinib
      7. Ponatinib
      8. Axitinib
      9. Tivozanib
      10. Vandetanib
      11. Anlotinib
      12. Apatinib
      13. Fruquintinib
      14. Surufatinib
    2. Biologics
      1. Bevacizumab
      2. Aflibercept
      3. Ramucirumab
  4. Anti-VEGF Market, By Type (2022-2030)
    1. VEGF-A Inhibitors
    2. VEGF-B Inhibitors
    3. VEGF-C Inhibitors
    4. Placenta Growth Factor Inhibitors
  5. Anti-VEGF Market, By Distribution Channel (2022-2030)
    1. Hospitals
    2. Specialty Clinics
    3. Mail Order Pharmacies
    1. North America
      1. North America Anti-VEGF Market, By Product
        1. Eylea
          1. Lucentis
            1. Beovu
            2. North America Anti-VEGF Market, By Disease
              1. Macular Edema
                1. Diabetic Retinopathy
                  1. Retinal Vein Occlusion
                    1. Age-Related Macular Degeneration
                    2. North America Anti-VEGF Market, By Drug
                      1. Small Molecules
                        1. Pazopanib
                          1. Sunitinib
                            1. Sorafenib
                              1. Regorafenib
                                1. Cabozantinib
                                  1. Lenvatinib
                                    1. Ponatinib
                                      1. Axitinib
                                        1. Tivozanib
                                          1. Vandetanib
                                            1. Anlotinib
                                              1. Apatinib
                                                1. Fruquintinib
                                                  1. Surufatinib
                                                  2. Biologics
                                                    1. Bevacizumab
                                                      1. Aflibercept
                                                        1. Ramucirumab
                                                      2. North America Anti-VEGF Market, By Type
                                                        1. VEGF-A Inhibitors
                                                          1. VEGF-B Inhibitors
                                                            1. VEGF-C Inhibitors
                                                              1. Placenta Growth Factor Inhibitors
                                                              2. North America Anti-VEGF Market, By Distribution Channel
                                                                1. Hospitals
                                                                  1. Specialty Clinics
                                                                    1. Mail Order Pharmacies
                                                                    2. U.S.
                                                                      1. U.S. Anti-VEGF Market, By Product
                                                                        1. Eylea
                                                                          1. Lucentis
                                                                            1. Beovu
                                                                            2. U.S. Anti-VEGF Market, By Disease
                                                                              1. Macular Edema
                                                                                1. Diabetic Retinopathy
                                                                                  1. Retinal Vein Occlusion
                                                                                    1. Age-Related Macular Degeneration
                                                                                    2. U.S. Anti-VEGF Market, By Drug
                                                                                      1. Small Molecules
                                                                                        1. Pazopanib
                                                                                          1. Sunitinib
                                                                                            1. Sorafenib
                                                                                              1. Regorafenib
                                                                                                1. Cabozantinib
                                                                                                  1. Lenvatinib
                                                                                                    1. Ponatinib
                                                                                                      1. Axitinib
                                                                                                        1. Tivozanib
                                                                                                          1. Vandetanib
                                                                                                            1. Anlotinib
                                                                                                              1. Apatinib
                                                                                                                1. Fruquintinib
                                                                                                                  1. Surufatinib
                                                                                                                  2. Biologics
                                                                                                                    1. Bevacizumab
                                                                                                                      1. Aflibercept
                                                                                                                        1. Ramucirumab
                                                                                                                      2. U.S. Anti-VEGF Market, By Type
                                                                                                                        1. VEGF-A Inhibitors
                                                                                                                          1. VEGF-B Inhibitors
                                                                                                                            1. VEGF-C Inhibitors
                                                                                                                              1. Placenta Growth Factor Inhibitors
                                                                                                                              2. U.S. Anti-VEGF Market, By Distribution Channel
                                                                                                                                1. Hospitals
                                                                                                                                  1. Specialty Clinics
                                                                                                                                    1. Mail Order Pharmacies
                                                                                                                                  2. Canada
                                                                                                                                2. Europe
                                                                                                                                  1. Europe Anti-VEGF Market, By Product
                                                                                                                                    1. Eylea
                                                                                                                                      1. Lucentis
                                                                                                                                        1. Beovu
                                                                                                                                        2. Europe Anti-VEGF Market, By Disease
                                                                                                                                          1. Macular Edema
                                                                                                                                            1. Diabetic Retinopathy
                                                                                                                                              1. Retinal Vein Occlusion
                                                                                                                                                1. Age-Related Macular Degeneration
                                                                                                                                                2. Europe Anti-VEGF Market, By Drug
                                                                                                                                                  1. Small Molecules
                                                                                                                                                    1. Pazopanib
                                                                                                                                                      1. Sunitinib
                                                                                                                                                        1. Sorafenib
                                                                                                                                                          1. Regorafenib
                                                                                                                                                            1. Cabozantinib
                                                                                                                                                              1. Lenvatinib
                                                                                                                                                                1. Ponatinib
                                                                                                                                                                  1. Axitinib
                                                                                                                                                                    1. Tivozanib
                                                                                                                                                                      1. Vandetanib
                                                                                                                                                                        1. Anlotinib
                                                                                                                                                                          1. Apatinib
                                                                                                                                                                            1. Fruquintinib
                                                                                                                                                                              1. Surufatinib
                                                                                                                                                                              2. Biologics
                                                                                                                                                                                1. Bevacizumab
                                                                                                                                                                                  1. Aflibercept
                                                                                                                                                                                    1. Ramucirumab
                                                                                                                                                                                  2. Europe Anti-VEGF Market, By Type
                                                                                                                                                                                    1. VEGF-A Inhibitors
                                                                                                                                                                                      1. VEGF-B Inhibitors
                                                                                                                                                                                        1. VEGF-C Inhibitors
                                                                                                                                                                                          1. Placenta Growth Factor Inhibitors
                                                                                                                                                                                          2. Europe Anti-VEGF Market, By Distribution Channel
                                                                                                                                                                                            1. Hospitals
                                                                                                                                                                                              1. Specialty Clinics
                                                                                                                                                                                                1. Mail Order Pharmacies
                                                                                                                                                                                                2. U.K.
                                                                                                                                                                                                  1. U.K. Anti-VEGF Market, By Product
                                                                                                                                                                                                    1. Eylea
                                                                                                                                                                                                      1. Lucentis
                                                                                                                                                                                                        1. Beovu
                                                                                                                                                                                                        2. U.K. Anti-VEGF Market, By Disease
                                                                                                                                                                                                          1. Macular Edema
                                                                                                                                                                                                            1. Diabetic Retinopathy
                                                                                                                                                                                                              1. Retinal Vein Occlusion
                                                                                                                                                                                                                1. Age-Related Macular Degeneration
                                                                                                                                                                                                                2. U.K. Anti-VEGF Market, By Drug
                                                                                                                                                                                                                  1. Small Molecules
                                                                                                                                                                                                                    1. Pazopanib
                                                                                                                                                                                                                      1. Sunitinib
                                                                                                                                                                                                                        1. Sorafenib
                                                                                                                                                                                                                          1. Regorafenib
                                                                                                                                                                                                                            1. Cabozantinib
                                                                                                                                                                                                                              1. Lenvatinib
                                                                                                                                                                                                                                1. Ponatinib
                                                                                                                                                                                                                                  1. Axitinib
                                                                                                                                                                                                                                    1. Tivozanib
                                                                                                                                                                                                                                      1. Vandetanib
                                                                                                                                                                                                                                        1. Anlotinib
                                                                                                                                                                                                                                          1. Apatinib
                                                                                                                                                                                                                                            1. Fruquintinib
                                                                                                                                                                                                                                              1. Surufatinib
                                                                                                                                                                                                                                              2. Biologics
                                                                                                                                                                                                                                                1. Bevacizumab
                                                                                                                                                                                                                                                  1. Aflibercept
                                                                                                                                                                                                                                                    1. Ramucirumab
                                                                                                                                                                                                                                                  2. U.K. Anti-VEGF Market, By Type
                                                                                                                                                                                                                                                    1. VEGF-A Inhibitors
                                                                                                                                                                                                                                                      1. VEGF-B Inhibitors
                                                                                                                                                                                                                                                        1. VEGF-C Inhibitors
                                                                                                                                                                                                                                                          1. Placenta Growth Factor Inhibitors
                                                                                                                                                                                                                                                          2. U.K. Anti-VEGF Market, By Distribution Channel
                                                                                                                                                                                                                                                            1. Hospitals
                                                                                                                                                                                                                                                              1. Specialty Clinics
                                                                                                                                                                                                                                                                1. Mail Order Pharmacies
                                                                                                                                                                                                                                                              2. Germany
                                                                                                                                                                                                                                                              3. France
                                                                                                                                                                                                                                                              4. Spain
                                                                                                                                                                                                                                                              5. Italy
                                                                                                                                                                                                                                                              6. Russia
                                                                                                                                                                                                                                                              7. Nordic
                                                                                                                                                                                                                                                              8. Benelux
                                                                                                                                                                                                                                                              9. Rest of Europe
                                                                                                                                                                                                                                                            2. APAC
                                                                                                                                                                                                                                                              1. APAC Anti-VEGF Market, By Product
                                                                                                                                                                                                                                                                1. Eylea
                                                                                                                                                                                                                                                                  1. Lucentis
                                                                                                                                                                                                                                                                    1. Beovu
                                                                                                                                                                                                                                                                    2. APAC Anti-VEGF Market, By Disease
                                                                                                                                                                                                                                                                      1. Macular Edema
                                                                                                                                                                                                                                                                        1. Diabetic Retinopathy
                                                                                                                                                                                                                                                                          1. Retinal Vein Occlusion
                                                                                                                                                                                                                                                                            1. Age-Related Macular Degeneration
                                                                                                                                                                                                                                                                            2. APAC Anti-VEGF Market, By Drug
                                                                                                                                                                                                                                                                              1. Small Molecules
                                                                                                                                                                                                                                                                                1. Pazopanib
                                                                                                                                                                                                                                                                                  1. Sunitinib
                                                                                                                                                                                                                                                                                    1. Sorafenib
                                                                                                                                                                                                                                                                                      1. Regorafenib
                                                                                                                                                                                                                                                                                        1. Cabozantinib
                                                                                                                                                                                                                                                                                          1. Lenvatinib
                                                                                                                                                                                                                                                                                            1. Ponatinib
                                                                                                                                                                                                                                                                                              1. Axitinib
                                                                                                                                                                                                                                                                                                1. Tivozanib
                                                                                                                                                                                                                                                                                                  1. Vandetanib
                                                                                                                                                                                                                                                                                                    1. Anlotinib
                                                                                                                                                                                                                                                                                                      1. Apatinib
                                                                                                                                                                                                                                                                                                        1. Fruquintinib
                                                                                                                                                                                                                                                                                                          1. Surufatinib
                                                                                                                                                                                                                                                                                                          2. Biologics
                                                                                                                                                                                                                                                                                                            1. Bevacizumab
                                                                                                                                                                                                                                                                                                              1. Aflibercept
                                                                                                                                                                                                                                                                                                                1. Ramucirumab
                                                                                                                                                                                                                                                                                                              2. APAC Anti-VEGF Market, By Type
                                                                                                                                                                                                                                                                                                                1. VEGF-A Inhibitors
                                                                                                                                                                                                                                                                                                                  1. VEGF-B Inhibitors
                                                                                                                                                                                                                                                                                                                    1. VEGF-C Inhibitors
                                                                                                                                                                                                                                                                                                                      1. Placenta Growth Factor Inhibitors
                                                                                                                                                                                                                                                                                                                      2. APAC Anti-VEGF Market, By Distribution Channel
                                                                                                                                                                                                                                                                                                                        1. Hospitals
                                                                                                                                                                                                                                                                                                                          1. Specialty Clinics
                                                                                                                                                                                                                                                                                                                            1. Mail Order Pharmacies
                                                                                                                                                                                                                                                                                                                            2. China
                                                                                                                                                                                                                                                                                                                              1. China Anti-VEGF Market, By Product
                                                                                                                                                                                                                                                                                                                                1. Eylea
                                                                                                                                                                                                                                                                                                                                  1. Lucentis
                                                                                                                                                                                                                                                                                                                                    1. Beovu
                                                                                                                                                                                                                                                                                                                                    2. China Anti-VEGF Market, By Disease
                                                                                                                                                                                                                                                                                                                                      1. Macular Edema
                                                                                                                                                                                                                                                                                                                                        1. Diabetic Retinopathy
                                                                                                                                                                                                                                                                                                                                          1. Retinal Vein Occlusion
                                                                                                                                                                                                                                                                                                                                            1. Age-Related Macular Degeneration
                                                                                                                                                                                                                                                                                                                                            2. China Anti-VEGF Market, By Drug
                                                                                                                                                                                                                                                                                                                                              1. Small Molecules
                                                                                                                                                                                                                                                                                                                                                1. Pazopanib
                                                                                                                                                                                                                                                                                                                                                  1. Sunitinib
                                                                                                                                                                                                                                                                                                                                                    1. Sorafenib
                                                                                                                                                                                                                                                                                                                                                      1. Regorafenib
                                                                                                                                                                                                                                                                                                                                                        1. Cabozantinib
                                                                                                                                                                                                                                                                                                                                                          1. Lenvatinib
                                                                                                                                                                                                                                                                                                                                                            1. Ponatinib
                                                                                                                                                                                                                                                                                                                                                              1. Axitinib
                                                                                                                                                                                                                                                                                                                                                                1. Tivozanib
                                                                                                                                                                                                                                                                                                                                                                  1. Vandetanib
                                                                                                                                                                                                                                                                                                                                                                    1. Anlotinib
                                                                                                                                                                                                                                                                                                                                                                      1. Apatinib
                                                                                                                                                                                                                                                                                                                                                                        1. Fruquintinib
                                                                                                                                                                                                                                                                                                                                                                          1. Surufatinib
                                                                                                                                                                                                                                                                                                                                                                          2. Biologics
                                                                                                                                                                                                                                                                                                                                                                            1. Bevacizumab
                                                                                                                                                                                                                                                                                                                                                                              1. Aflibercept
                                                                                                                                                                                                                                                                                                                                                                                1. Ramucirumab
                                                                                                                                                                                                                                                                                                                                                                              2. China Anti-VEGF Market, By Type
                                                                                                                                                                                                                                                                                                                                                                                1. VEGF-A Inhibitors
                                                                                                                                                                                                                                                                                                                                                                                  1. VEGF-B Inhibitors
                                                                                                                                                                                                                                                                                                                                                                                    1. VEGF-C Inhibitors
                                                                                                                                                                                                                                                                                                                                                                                      1. Placenta Growth Factor Inhibitors
                                                                                                                                                                                                                                                                                                                                                                                      2. China Anti-VEGF Market, By Distribution Channel
                                                                                                                                                                                                                                                                                                                                                                                        1. Hospitals
                                                                                                                                                                                                                                                                                                                                                                                          1. Specialty Clinics
                                                                                                                                                                                                                                                                                                                                                                                            1. Mail Order Pharmacies
                                                                                                                                                                                                                                                                                                                                                                                          2. Korea
                                                                                                                                                                                                                                                                                                                                                                                          3. Japan
                                                                                                                                                                                                                                                                                                                                                                                          4. India
                                                                                                                                                                                                                                                                                                                                                                                          5. Australia
                                                                                                                                                                                                                                                                                                                                                                                          6. Taiwan
                                                                                                                                                                                                                                                                                                                                                                                          7. South East Asia
                                                                                                                                                                                                                                                                                                                                                                                          8. Rest of Asia-Pacific
                                                                                                                                                                                                                                                                                                                                                                                        2. Middle East and Africa
                                                                                                                                                                                                                                                                                                                                                                                          1. Middle East and Africa Anti-VEGF Market, By Product
                                                                                                                                                                                                                                                                                                                                                                                            1. Eylea
                                                                                                                                                                                                                                                                                                                                                                                              1. Lucentis
                                                                                                                                                                                                                                                                                                                                                                                                1. Beovu
                                                                                                                                                                                                                                                                                                                                                                                                2. Middle East and Africa Anti-VEGF Market, By Disease
                                                                                                                                                                                                                                                                                                                                                                                                  1. Macular Edema
                                                                                                                                                                                                                                                                                                                                                                                                    1. Diabetic Retinopathy
                                                                                                                                                                                                                                                                                                                                                                                                      1. Retinal Vein Occlusion
                                                                                                                                                                                                                                                                                                                                                                                                        1. Age-Related Macular Degeneration
                                                                                                                                                                                                                                                                                                                                                                                                        2. Middle East and Africa Anti-VEGF Market, By Drug
                                                                                                                                                                                                                                                                                                                                                                                                          1. Small Molecules
                                                                                                                                                                                                                                                                                                                                                                                                            1. Pazopanib
                                                                                                                                                                                                                                                                                                                                                                                                              1. Sunitinib
                                                                                                                                                                                                                                                                                                                                                                                                                1. Sorafenib
                                                                                                                                                                                                                                                                                                                                                                                                                  1. Regorafenib
                                                                                                                                                                                                                                                                                                                                                                                                                    1. Cabozantinib
                                                                                                                                                                                                                                                                                                                                                                                                                      1. Lenvatinib
                                                                                                                                                                                                                                                                                                                                                                                                                        1. Ponatinib
                                                                                                                                                                                                                                                                                                                                                                                                                          1. Axitinib
                                                                                                                                                                                                                                                                                                                                                                                                                            1. Tivozanib
                                                                                                                                                                                                                                                                                                                                                                                                                              1. Vandetanib
                                                                                                                                                                                                                                                                                                                                                                                                                                1. Anlotinib
                                                                                                                                                                                                                                                                                                                                                                                                                                  1. Apatinib
                                                                                                                                                                                                                                                                                                                                                                                                                                    1. Fruquintinib
                                                                                                                                                                                                                                                                                                                                                                                                                                      1. Surufatinib
                                                                                                                                                                                                                                                                                                                                                                                                                                      2. Biologics
                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Bevacizumab
                                                                                                                                                                                                                                                                                                                                                                                                                                          1. Aflibercept
                                                                                                                                                                                                                                                                                                                                                                                                                                            1. Ramucirumab
                                                                                                                                                                                                                                                                                                                                                                                                                                          2. Middle East and Africa Anti-VEGF Market, By Type
                                                                                                                                                                                                                                                                                                                                                                                                                                            1. VEGF-A Inhibitors
                                                                                                                                                                                                                                                                                                                                                                                                                                              1. VEGF-B Inhibitors
                                                                                                                                                                                                                                                                                                                                                                                                                                                1. VEGF-C Inhibitors
                                                                                                                                                                                                                                                                                                                                                                                                                                                  1. Placenta Growth Factor Inhibitors
                                                                                                                                                                                                                                                                                                                                                                                                                                                  2. Middle East and Africa Anti-VEGF Market, By Distribution Channel
                                                                                                                                                                                                                                                                                                                                                                                                                                                    1. Hospitals
                                                                                                                                                                                                                                                                                                                                                                                                                                                      1. Specialty Clinics
                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Mail Order Pharmacies
                                                                                                                                                                                                                                                                                                                                                                                                                                                        2. UAE
                                                                                                                                                                                                                                                                                                                                                                                                                                                          1. UAE Anti-VEGF Market, By Product
                                                                                                                                                                                                                                                                                                                                                                                                                                                            1. Eylea
                                                                                                                                                                                                                                                                                                                                                                                                                                                              1. Lucentis
                                                                                                                                                                                                                                                                                                                                                                                                                                                                1. Beovu
                                                                                                                                                                                                                                                                                                                                                                                                                                                                2. UAE Anti-VEGF Market, By Disease
                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1. Macular Edema
                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1. Diabetic Retinopathy
                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1. Retinal Vein Occlusion
                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Age-Related Macular Degeneration
                                                                                                                                                                                                                                                                                                                                                                                                                                                                        2. UAE Anti-VEGF Market, By Drug
                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1. Small Molecules
                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1. Pazopanib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1. Sunitinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1. Sorafenib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1. Regorafenib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1. Cabozantinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1. Lenvatinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Ponatinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1. Axitinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1. Tivozanib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1. Vandetanib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1. Anlotinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1. Apatinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1. Fruquintinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1. Surufatinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      2. Biologics
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Bevacizumab
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1. Aflibercept
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1. Ramucirumab
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          2. UAE Anti-VEGF Market, By Type
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1. VEGF-A Inhibitors
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1. VEGF-B Inhibitors
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1. VEGF-C Inhibitors
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1. Placenta Growth Factor Inhibitors
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  2. UAE Anti-VEGF Market, By Distribution Channel
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1. Hospitals
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1. Specialty Clinics
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Mail Order Pharmacies
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1. LATAM Anti-VEGF Market, By Product
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Eylea
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1. Lucentis
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1. Beovu
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            2. LATAM Anti-VEGF Market, By Disease
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1. Macular Edema
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1. Diabetic Retinopathy
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1. Retinal Vein Occlusion
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1. Age-Related Macular Degeneration
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    2. LATAM Anti-VEGF Market, By Drug
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1. Small Molecules
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Pazopanib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1. Sunitinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1. Sorafenib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1. Regorafenib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1. Cabozantinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1. Lenvatinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1. Ponatinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1. Axitinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Tivozanib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1. Vandetanib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1. Anlotinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1. Apatinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1. Fruquintinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1. Surufatinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  2. Biologics
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1. Bevacizumab
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1. Aflibercept
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Ramucirumab
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      2. LATAM Anti-VEGF Market, By Type
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. VEGF-A Inhibitors
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1. VEGF-B Inhibitors
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1. VEGF-C Inhibitors
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1. Placenta Growth Factor Inhibitors
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              2. LATAM Anti-VEGF Market, By Distribution Channel
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1. Hospitals
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1. Specialty Clinics
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1. Mail Order Pharmacies
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    2. Brazil
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1. Brazil Anti-VEGF Market, By Product
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Eylea
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1. Lucentis
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1. Beovu
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            2. Brazil Anti-VEGF Market, By Disease
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1. Macular Edema
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1. Diabetic Retinopathy
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1. Retinal Vein Occlusion
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1. Age-Related Macular Degeneration
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    2. Brazil Anti-VEGF Market, By Drug
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1. Small Molecules
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Pazopanib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1. Sunitinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1. Sorafenib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1. Regorafenib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1. Cabozantinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1. Lenvatinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1. Ponatinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1. Axitinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Tivozanib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1. Vandetanib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1. Anlotinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1. Apatinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1. Fruquintinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1. Surufatinib
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  2. Biologics
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1. Bevacizumab
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1. Aflibercept
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. Ramucirumab
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      2. Brazil Anti-VEGF Market, By Type
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1. VEGF-A Inhibitors
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1. VEGF-B Inhibitors
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1. VEGF-C Inhibitors
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1. Placenta Growth Factor Inhibitors
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              2. Brazil Anti-VEGF Market, By Distribution Channel
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1. Hospitals
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1. Specialty Clinics
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1. Mail Order Pharmacies
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  2. Mexico
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  3. Argentina
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  4. Chile
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  5. Colombia
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  6. Rest of LATAM

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Related Reports

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Global Report
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Anti-venoms consist of anti-bodies that are used to treat venomous stings or bites. The growing prevalence of snake bites and other animals bite such as fish stings are the drivers of the anti-venom market. According to WHO, 4.5 to 5.4 million people
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Buy Now

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Purchase Benefits

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              • Completely customizable scope
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              • 30% discount on your next purchase
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              • Dedicated account manager
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              • Query resolution within 24 hours
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              • Permission to print the report

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              We are featured on :

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              This website uses cookies to ensure you get the best experience on our website. Privacy Policy

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              www.straitsresearch.com
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              © Copyright . All rights Reserved.